IL-6 is a pro-inflammatory cytokine highly expressed in the tumor context of type-2 ovarian cancers and in ascitic fluid, and its level correlates with poor prognosis in ovarian cancer patients[76,77]. Here, IL6 is linked to ovarian cancer.